Conference
Phase II Testing of Lenalidomide Plus Melphalan for Previously Untreated Older Patients with Multiple Myeloma: The NCIC CTG MY.11 Trial.
Authors
White DJ; Bahlis NJ; Marcellus DC; Belch A; Stewart AK; Chen C; Kovacs MJ; Macdonald DA; Reece DE; Harnett E
Volume
112
Pagination
pp. 954-955
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2008
Name of conference
50th Annual Meeting of the American-Society-of-Hematology
Conference place
San Francisco, CA
Conference start date
December 6, 2008
Conference end date
December 9, 2008
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971